RATIOS
Orchid Pharma Ltd.
BSE
Jul 04
755.30
+7.90 (+ 1.06%)
Volume
8752
Prev. Close
747.40
Open Price
747.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 04
756.05
+8.50 (+ 1.14%)
Volume
163098
Prev. Close
747.55
Open Price
753.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE191A01027
|
Market Cap. ( ₹ in Cr. )
|
3834.62
|
P/BV
|
3.13
|
Book Value ( ₹ )
|
241.38
|
|
BSE Code
|
524372
|
52 Week High/Low ( ₹ )
|
1997/604
|
FV/ML
|
10/1
|
P/E(X)
|
38.48
|
|
NSE Code
|
ORCHPHARMAEQ
|
Book Closure
|
09/08/2023
|
EPS ( ₹ )
|
19.65
|
Div Yield (%)
|
0.00
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 20.99 | 19.59 | 13.28 | -1.18 | -28.70 |
| Diluted EPS (Rs.) | 20.99 | 19.59 | 13.28 | -1.18 | -28.70 |
| Cash EPS (Rs.) | 27.78 | 25.23 | 26.70 | 6.67 | -2.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 261.06 | 240.21 | 179.33 | 166.10 | 166.93 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 261.06 | 240.21 | 179.33 | 166.10 | 166.93 |
| Revenue From Operations / Share (Rs.) | 181.77 | 161.55 | 163.14 | 136.46 | 110.42 |
| PBDIT / Share (Rs.) | 30.65 | 27.81 | 25.25 | 16.23 | 15.77 |
| PBIT / Share (Rs.) | 23.86 | 21.26 | 11.82 | 8.39 | -10.91 |
| PBT / Share (Rs.) | 20.99 | 18.05 | 13.54 | -12.93 | -23.49 |
| Net Profit / Share (Rs.) | 20.99 | 18.68 | 13.28 | -1.18 | -28.70 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 16.86 | 17.21 | 15.47 | 11.89 | 14.28 |
| PBIT Margin (%) | 13.12 | 13.16 | 7.24 | 6.14 | -9.88 |
| PBT Margin (%) | 11.55 | 11.16 | 8.29 | -9.47 | -21.27 |
| Net Profit Margin (%) | 11.55 | 11.56 | 8.13 | -0.86 | -25.99 |
| Return on Networth / Equity (%) | 8.04 | 7.77 | 7.40 | -0.70 | -17.19 |
| Return on Capital Employeed (%) | 8.29 | 8.03 | 5.38 | 3.80 | -3.96 |
| Return On Assets (%) | 6.27 | 6.10 | 4.42 | -0.43 | -9.56 |
| Long Term Debt / Equity (X) | 0.09 | 0.09 | 0.20 | 0.30 | 0.62 |
| Total Debt / Equity (X) | 0.13 | 0.11 | 0.45 | 0.39 | 0.63 |
| Asset Turnover Ratio (%) | 0.56 | 0.59 | 0.57 | 0.48 | 0.30 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 3.31 | 3.73 | 1.51 | 2.25 | 5.38 |
| Quick Ratio (X) | 1.94 | 2.47 | 0.81 | 1.36 | 3.88 |
| Inventory Turnover Ratio (X) | 1.98 | 2.14 | 2.02 | 2.08 | 1.60 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 10.69 | 8.64 | 3.20 | 0.76 | 1.25 |
| Interest Coverage Ratio (Post Tax) (%) | 8.32 | 6.80 | 1.50 | 0.39 | -0.86 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 3950.32 | 5178.19 | 1877.99 | 1424.16 | 10473.23 |
| EV / Net Operating Revenue (X) | 4.28 | 6.32 | 2.82 | 2.56 | 23.24 |
| EV / EBITDA (X) | 25.41 | 36.71 | 18.22 | 21.49 | 162.72 |
| MarketCap / Net Operating Revenue (X) | 4.27 | 6.47 | 2.36 | 2.08 | 22.33 |
| Price / BV (X) | 2.98 | 4.35 | 2.14 | 1.71 | 14.77 |
| Price / Net Operating Revenue (X) | 4.27 | 6.47 | 2.36 | 2.08 | 22.33 |
| EarningsYield | 0.02 | 0.01 | 0.03 | 0.00 | -0.01 |